Look no further for comprehensive and solutions-focused content aimed at keeping your facility on the pulse of changing regulations, ensuring quality and compliance within compounding systems and processes and providing implementable tactics to leverage the latest innovations within the evolving compounding landscape. Featuring expert perspective from FDA, Merck, Nephron Pharmaceuticals, Innovative Compounding, National Association Boards of Pharmacy, Wedgewood Pharmacy, Rockefeller University Hospital, St. Jude Children's Research Hospital and so many more, do not delay in joining these influential stakeholders.

Unparalleled Perspectives from Regulatory and Industry Experts, Including:

Michael Blaire,

Vice President,

Government & Regulatory Affairs, Wedgewood Pharmacy; Member, Arizona State Board of Pharmacy

Melissa Madigan, Associate Executive Director, Policy and Communications, National Association of Boards of Pharmacy

Gail Bormel, R.P.h ., J.D., Associate Director for Compounding, FDA

Lou Kennedy, President, Chief Executive Officer, Owner, Nephron Pharmaceuticals

Robert B. MacArthur, Pharm.D., MS, Director of Pharmacy, Rockefeller University Hospital

Helen McKnight, PharmD, MBA, BCSCP, Director of Pharmacy, Princeton Baptist Medical Center

Masoud Rashidi, Pharm.D., CEO/President and Chief Compounding Pharmacist, Innovative Compounding

Jenni Wai, RPh., MBA, Chief Pharmacist, State of Ohio Board of Pharmacy

informaconnect.com/compounding

Follow RXinsider on Social Media